Found: 15
Select item for more details and to access through your institution.
Assessing and Overcoming Resistance Phenomena against a Genetically Modified Vaccinia Virus in Selected Cancer Cell Lines.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 20, p. 7618, doi. 10.3390/ijms21207618
- By:
- Publication type:
- Article
Suicide gene-armed measles vaccine virus for the treatment of AML.
- Published in:
- International Journal of Oncology, 2019, v. 55, n. 2, p. 347, doi. 10.3892/ijo.2019.4835
- By:
- Publication type:
- Article
Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus.
- Published in:
- International Journal of Oncology, 2016, v. 49, n. 5, p. 1931, doi. 10.3892/ijo.2016.3675
- By:
- Publication type:
- Article
Evidence for Intercellular Trafficking of VP22 in Living Cells.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 2, p. 310, doi. 10.1038/sj.mt.6300013
- By:
- Publication type:
- Article
840. Recombinant Sendai Virus Vectors with Matrix Protein Gene Deletion Restore Dendritic Cell Allostimulatory Activity
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090508
- By:
- Publication type:
- Article
In Vitro Sensitivity of Neuroendocrine Neoplasms to an Armed Oncolytic Measles Vaccine Virus.
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 488, doi. 10.3390/cancers16030488
- By:
- Publication type:
- Article
Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 368, doi. 10.3390/cancers16020368
- By:
- Publication type:
- Article
Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2761, doi. 10.3390/cancers14112761
- By:
- Publication type:
- Article
The Oncolytic Herpes Simplex Virus Talimogene Laherparepvec Shows Promising Efficacy in Neuroendocrine Cancer Cell Lines.
- Published in:
- Neuroendocrinology, 2019, v. 109, n. 4, p. 346, doi. 10.1159/000500159
- By:
- Publication type:
- Article
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multimodal Therapy Approaches for NUT Carcinoma by Dual Combination of Oncolytic Virus Talimogene Laherparepvec with Small Molecule Inhibitors.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 5, p. 775, doi. 10.3390/v16050775
- By:
- Publication type:
- Article
Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 2, p. 363, doi. 10.3390/v15020363
- By:
- Publication type:
- Article
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 7, p. 614, doi. 10.3390/v11070614
- By:
- Publication type:
- Article